Caffeine Drug Interactions and its Clinical Implication After Acute Coronary Syndrome: A Literature Review.

Q3 Medicine Critical Pathways in Cardiology Pub Date : 2023-09-01 Epub Date: 2023-05-09 DOI:10.1097/HPC.0000000000000322

Ramin Yaghoobian, Mohammad Sharifi, Malihe Rezaee, Hamed Vahidi, Negin Salehi, Kaveh Hosseini

{"title":"Caffeine Drug Interactions and its Clinical Implication After Acute Coronary Syndrome: A Literature Review.","authors":"Ramin Yaghoobian, Mohammad Sharifi, Malihe Rezaee, Hamed Vahidi, Negin Salehi, Kaveh Hosseini","doi":"10.1097/HPC.0000000000000322","DOIUrl":null,"url":null,"abstract":"<p><p>The hemodynamic and cardiovascular impacts of coffee and caffeine have long been controversial. However, due to the worldwide popularity of coffee and caffeinated beverages, it is essential to understand how they affect the cardiovascular system, specifically in patients with a history of acute coronary syndrome. This literature review was conducted to explore the cardiovascular effects of coffee and caffeine and their interactions with common drugs after acute coronary syndrome and percutaneous coronary intervention. The evidence suggests that moderate coffee and caffeine consumption is not associated with cardiovascular disease in healthy individuals and patients with a history of acute coronary syndrome. The interactions of coffee or caffeine with common medications after acute coronary syndrome or percutaneous coronary intervention are less studied. However, based on the current human studies in this field, the only interaction is with the protective effect of statins on cardiac ischemia.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":"22 3","pages":"95-99"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Pathways in Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/HPC.0000000000000322","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

The hemodynamic and cardiovascular impacts of coffee and caffeine have long been controversial. However, due to the worldwide popularity of coffee and caffeinated beverages, it is essential to understand how they affect the cardiovascular system, specifically in patients with a history of acute coronary syndrome. This literature review was conducted to explore the cardiovascular effects of coffee and caffeine and their interactions with common drugs after acute coronary syndrome and percutaneous coronary intervention. The evidence suggests that moderate coffee and caffeine consumption is not associated with cardiovascular disease in healthy individuals and patients with a history of acute coronary syndrome. The interactions of coffee or caffeine with common medications after acute coronary syndrome or percutaneous coronary intervention are less studied. However, based on the current human studies in this field, the only interaction is with the protective effect of statins on cardiac ischemia.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

急性冠状动脉综合征后咖啡因与药物的相互作用及其临床意义：文献综述。

咖啡和咖啡因对血流动力学和心血管的影响一直存在争议。然而，由于咖啡和含咖啡因饮料在全球范围内的流行，了解它们对心血管系统的影响至关重要，尤其是对有急性冠状动脉综合征病史的患者。本文献综述旨在探讨咖啡和咖啡因在急性冠状动脉综合征和经皮冠状动脉介入治疗后对心血管的影响及其与常见药物的相互作用。有证据表明，在健康人和有急性冠状动脉综合征病史的患者中，适度饮用咖啡和咖啡因与心血管疾病无关。咖啡或咖啡因与常见药物在急性冠状动脉综合征或经皮冠状动脉介入治疗后的相互作用研究较少。然而，根据目前该领域的人类研究，唯一的相互作用是他汀类药物对心脏缺血的保护作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Critical Pathways in Cardiology Medicine-Medicine (all)

CiteScore

1.90

自引率

0.00%

发文量

期刊介绍： Critical Pathways in Cardiology provides a single source for the diagnostic and therapeutic protocols in use at hospitals worldwide for patients with cardiac disorders. The Journal presents critical pathways for specific diagnoses—complete with evidence-based rationales—and also publishes studies of these protocols" effectiveness.